Literature DB >> 14996301

Fas-induced apoptosis is a feature of progressive diabetic nephropathy in transgenic (mRen-2)27 rats: attenuation with renin-angiotensin blockade.

Darren J Kelly1, Alicia Stein-Oakley, Yuan Zhang, Lesley Wassef, Julie Maguire, Takehiko Koji, Napier Thomson, Jennifer L Wilkinson-Berka, Richard E Gilbert.   

Abstract

BACKGROUND AND AIM: Tubular atrophy is a major feature of most renal diseases and is closely associated with the loss of renal function. The present study sought to investigate whether Fas/FasL-induced tubular epithelial cell apoptosis was a feature of experimental diabetic nephropathy. The effects of renoprotective therapy with blockade of the renin-angiotensin (RAS) system were also examined.
METHOD: Six-week-old female Ren-2 rats were injected with streptozotocin and maintained diabetic for 12 weeks. Further groups of diabetic rats were treated with the angiotensin-converting enzyme inhibitor, perindopril, for 12 weeks.
RESULTS: Widespread apoptosis, identified by using mediated Terminal dUTP nick-end labelling (TUNEL) staining was noted in the tubules of diabetic Ren-2 rats. These changes were associated with an increase in both Fas mRNA and Fas L (ligand) within the tubules (P < 0.01). Treatment of diabetic Ren-2 rats with perindopril (6 mg/kg per day) reduced the apoptosis to control levels and was associated with a reduction in Fas mRNA and Fas L protein (P < 0.05).
CONCLUSION: In conclusion, Fas/Fas L-induced tubular apoptosis is a feature of diabetic Ren-2 rats and is attenuated by the blockade of the RAS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14996301     DOI: 10.1111/j.1440-1797.2003.00227.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  8 in total

1.  Maternal undernourished fetal kidneys exhibit differential regulation of nephrogenic genes including downregulation of the Notch signaling pathway.

Authors:  Thomas R Magee; Sanaz A Tafti; Mina Desai; Qinghai Liu; Michael G Ross; Cynthia C Nast
Journal:  Reprod Sci       Date:  2011-01-27       Impact factor: 3.060

2.  The death ligand TRAIL in diabetic nephropathy.

Authors:  Corina Lorz; Alberto Benito-Martín; Anissa Boucherot; Alvaro C Ucero; Maria Pia Rastaldi; Anna Henger; Silvia Armelloni; Beatriz Santamaría; Celine C Berthier; Matthias Kretzler; Jesus Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-02-20       Impact factor: 10.121

3.  Role of the EGF receptor in PPARγ-mediated sodium and water transport in human proximal tubule cells.

Authors:  S Saad; J Zhang; R Yong; D Yaghobian; M G Wong; D J Kelly; X M Chen; C A Pollock
Journal:  Diabetologia       Date:  2013-01-31       Impact factor: 10.122

Review 4.  Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy.

Authors:  Runa Lindblom; Gavin Higgins; Melinda Coughlan; Judy B de Haan
Journal:  Rev Diabet Stud       Date:  2015-08-10

5.  Interplay between Akt and p38 MAPK pathways in the regulation of renal tubular cell apoptosis associated with diabetic nephropathy.

Authors:  Madhavi J Rane; Ye Song; Shunying Jin; Michelle T Barati; Rui Wu; Hina Kausar; Yi Tan; Yuehui Wang; Guihua Zhou; Jon B Klein; Xiaokun Li; Lu Cai
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-02

6.  Overexpression of angiotensinogen increases tubular apoptosis in diabetes.

Authors:  Fang Liu; Marie-Luise Brezniceanu; Chih-Chang Wei; Isabelle Chénier; Sébastien Sachetelli; Shao-Ling Zhang; Janos G Filep; Julie R Ingelfinger; John S D Chan
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

Review 7.  Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications.

Authors:  José M López-Novoa; Ana B Rodríguez-Peña; Alberto Ortiz; Carlos Martínez-Salgado; Francisco J López Hernández
Journal:  J Transl Med       Date:  2011-01-20       Impact factor: 5.531

8.  Bcl-2-modifying factor induces renal proximal tubular cell apoptosis in diabetic mice.

Authors:  Garnet J Lau; Nicolas Godin; Hasna Maachi; Chao-Sheng Lo; Shyh-Jong Wu; Jian-Xin Zhu; Marie-Luise Brezniceanu; Isabelle Chénier; Joelle Fragasso-Marquis; Jean-Baptiste Lattouf; Jean Ethier; Janos G Filep; Julie R Ingelfinger; Viji Nair; Matthias Kretzler; Clemens D Cohen; Shao-Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2011-12-30       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.